• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Toxic Air – The ‘Invisible Killer’ that Stifles 300 Million Children
On 24 October 2016 in Yenagoa, Bayelsa State, Nigeria, children pass in front of a flame fed by waste and rubber materials in order to make Kanda, a type of smoked meat, at an abattoir. Photo: UNICEF/Tanya BindraBy Baher KamalROME, Nov 1 2016 (IPS)About 300 million children in the world are living in areas with outdoor air so toxic – six or more times higher than international pollution guidelines – that it can cause serious health damage, including harming their brain development. This shocking finding has just been revealed by the United Nations Children’s Fund (UNICEF), in a new report — ‘Clear the...
Source: IPS Inter Press Service - Health - November 1, 2016 Category: Global & Universal Authors: Baher Kamal Tags: Climate Change Featured Global Headlines Health Humanitarian Emergencies IPS UN: Inside the Glasshouse Poverty & SDGs Source Type: news

Environmental Pollution: An Under-recognized Threat to Children’s Health, Especially in Low- and Middle-Income Countries
Conclusions Patterns of disease are changing rapidly in LMICs. Pollution-related chronic diseases are becoming more common. This shift presents a particular problem for children, who are proportionately more heavily exposed than are adults to environmental pollutants and for whom these exposures are especially dangerous. Better quantification of environmental exposures and stepped-up efforts to understand how to prevent exposures that cause disease are needed in LMICs and around the globe. To confront the global problem of disease caused by pollution, improved programs of public health monitoring and environmental protecti...
Source: EHP Research - March 1, 2016 Category: Environmental Health Authors: Web Admin Tags: Brief Communication March 2016 Source Type: research

Get the flu vaccine, reduce your risk of death
Last year was a lousy year for the flu vaccine. Hospitalizations for flu hit a nine-year high, and the vaccine prevented flu in only 23% of all recipients, compared with 50% to 60% of recipients in prior years. Why does the flu vaccine work well in some winters and not others? The flu vaccine primes the immune system to attack two proteins on the surface of the influenza A virus, hemagglutinin (H) and neuraminidase (N). Different flu strains have different combinations of these proteins — for example, the strains targeted by recent flu vaccines are H3N2 and H1N1. Unfortunately, the influenza virus is microbiology’s ans...
Source: New Harvard Health Information - September 15, 2015 Category: Consumer Health News Authors: John Ross, MD, FIDSA Tags: Cold and Flu Vaccines Flu Shot flu vaccine Source Type: news

The Quality Of Health Care You Receive Likely Depends On Your Skin Color
Unequal health care continues to be a serious problem for black Americans. More than a decade after the Institute of Medicine issued a landmark report showing that minority patients were less likely to receive the same quality health care as white patients, racial and ethnic disparities continue to plague the U.S. health care system. That report, which was published in 2002, indicated that even when both groups had similar insurance or the same ability to pay for care, black patients received inferior treatment to white patients. This still hold true, according to our investigation into dozens of studies about black health...
Source: Healthy Living - The Huffington Post - June 29, 2015 Category: Consumer Health News Source Type: news

Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia.
CONCLUSION: A significant proportion of adults continue to develop PCV7-serotype CAP in the era of childhood pneumococcal conjugate vaccination. These adults are more likely to have stroke and dementia as underlying co-morbid illnesses, and have a higher 30-day mortality. A combination of pneumococcal transmission factors, host factors and pneumococcal serotype specific characteristics are likely to explain these findings. PMID: 24508039 [PubMed - as supplied by publisher]
Source: Vaccine - February 6, 2014 Category: Allergy & Immunology Authors: Rodrigo C, Bewick T, Sheppard C, Greenwood S, Trotter C, Slack M, George R, Lim WS Tags: Vaccine Source Type: research

Determinants of early case‐fatality among stroke patients in Maputo, Mozambique and impact of in‐hospital complications
The burden of stroke is increasing in developing countries that struggle to manage it efficiently. We identified determinants of early case‐fatality among stroke patients in Maputo, Mozambique, to assess the impact of in‐hospital complications. Patients admitted to any hospital in Maputo with a new stroke event were prospectively registered (n = 651) according to the World Health Organization's STEPwise approach, in 2005–2006. We assessed the determinants of in‐hospital and 28‐day fatality, independently of age, gender and education, and computed population attributable fractions. In‐hospital mortality was ...
Source: International Journal of Stroke - January 1, 2013 Category: Neurology Authors: Joana Gomes, Albertino Damasceno, Carla Carrilho, Vitória Lobo, Hélder Lopes, Tavares Madede, Pius Pravinrai, Carla Silva‐Matos, Domingos Diogo, Ana Azevedo, Nuno Lunet Tags: Panorama Source Type: research

Pages: 1  2